Oncolytics Biotech (ONCY) gains 9.2% premarket after announcing a positive interim safety update from phase 2 IRENE trial at the 2021 San Antonio ...
News
- Oncolytics Biotech jumps 9% on positive data for breast cancer candidate | Seeking Alpha
- Texas Biomed breaks ground on animal care complex | TPR
File photo: Scientists at Texas Biomedical Research Institute in San Antonio used marmosets to help prevent birth defects caused by the Zika virus ...
- Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic ... - Benzinga
... presentation at the 2021 San Antonio Breast Cancer Symposium (SABCS). ... Posted in: BiotechNewsHealth CareGeneralbreast cancerBriefsPhase 3 ...
- Adicet soars on early clinical data for cancer cell therapy - San Francisco Business Times
Allogeneic therapies are a holy grail for cancer-focused biotech companies, promising to speed critical treatments into a broader range of health ...
- Exai Bio Secures $67.5 Million Series A Financing to Advance Next-Generation, RNA ... - BioSpace
--Founder to Present Supporting Data at San Antonio Breast Cancer Conference-- ... 2021 Vilcek Prize for Creative Promise in Biomedical Sciences ...